Answers are grounded in this paper and cite their sources.
Contrast-enhanced inner ear magnetic resonance imaging (MRI) provides clinicians with powerful structural and pathological information for the diagnosis of inner ear diseases. However, currently used gadolinium (Gd) chelate-mediated contrast-enhanced MRI conveys insufficient inner ear specificity, and Gd-based contrast agents have a short body retention time and cause severe ototoxicity. Herein, we present the rational design of a sensitive inner ear-specific nanoprobe (I-PUSPIO) for inner ear MRI that is composed of an ultrasmall iron oxide core, the IETP2 peptide, and polyethylene glycol. Such a well-defined nanostructure endows it with blood-labyrinth barrier crossing capacity, leading to a high accumulation rate in the inner ear and prolonged body retention. In vivo I-PUSPIO can enhance high-resolution MRI of cochlear tissue and shows no evidence of toxicity. This study demonstrates the potential of I-PUSPIO as a sensitive contrast agent for inner ear MRI in clinical settings.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: